Tazarotene loaded niosomal gel for effective acne treatment
Meena Kumari Vaishya*, Virendra Sharma, J.P.Rai
ONLINE ISSN : 2456-8244ABSTRACT
Niosomes are the non-ionic surfactant-based vesicular system which may enhance anti-acne efficacy by improving bioavailability and intra-follicular penetration of the tazarotene. In the present study, we prepared tazarotene-loaded niosomes which were further incorporated in the carbopol 934 gel to
alter the contact time to gain maximum benefits of the treatment. Prepared formulations of Niosome were optimized on basis of vesicle size, shape, surface charge and entrapment efficiency. % Entrapment efficiency and vesicle size of optimized Niosomes formulation (F-9) was found 78.85±0.25% and 212.4±0.32 nm respectively. Gel of F9 was formulated using carbopol 934 as the base. The in vitro anti acne activity of the niosomal gel was evaluated against Propionibacterium acnes using well diffusion method using clindamycin as the standard drug. The niosomal Gel NG-2 showed greater capacity (18.5±0.86, 19.0±0.7, 24.0±0.9) to inhibit bacterial growth than
corresponding to plain gel (10.0±0.5, 12.0±0.8, 14.0±0.7) at the concentration level of 10µg/ml, 20µg/ml and 30µg/ml respectively.
KEYWORDS
Tazarotene, noisome, gel, acne, stability, thin film hydration
DOI
REFERENCES
1. Teixeira V, Vieira R, Figueiredo A. Impacto
psicossocial da acne. Rev da Soc Port
Dermatol Venereol. 2012; 70(3): 291–296.
2. Nast A, Dréno B, Bettoli V, et al. European
evidence-based (S3) guidelines for the
treatment of acne. J Eur Acad Dermatol
Venereol. 2012; 26 (S1): 1–29.
3. Shah VP, Maibach HI, Topical Drug
Bioavailability, Bioequivalence, and
Penetration, 1, Springer, USA, 1993, 369-391.
4. Makeshwar K, Wasankar S. Niosomes: a
novel drug delivery system. Asian J. Pharm.
Res. 2013; 3: 16-20.
5. Goyal G, Garg T, Malik B, Chauhan G, Rath
G, Goyal AK. Development and
characterization of niosomal gel for topical
delivery of benzoyl peroxide, Drug Delivery,
2015; 22(8): 1027–1042.
6. Balakrishnan P, Shanmugam S, Lee WS et al.
Formulation and in vitro assessment of
minoxidil niosomes for enhanced skin
delivery. International Journal of
Pharmaceutics. 2009; 377 (1-2), 1–8.
7. Firthouse PUM, Halith SM, Wahab SU,
Sirajudeen M, Mohideen SK. Formulation
and evaluation of miconazole niosomes.
International Journal of PharmTech
Research. 2011; 3 (2): 1019–1022.
8. Sathali AAH, Sangeetha T. Formulation and
evaluation of ocular niosomal in situ gel of
levofloxacin hemihydrates. Journal of
Pharmacy Research. 2011; 4: 4331–4337.
9. Sathali AAH, Rajalakshmi G. Evaluation of
transdermal targeted niosomal drug delivery
of terbinafne hydrochloride. International
Journal of PharmTech Research. 2010; 2 (3):
2081–2089.
10. Solanki AB, Parikh JR, Parikh RH, Patel MR.
Evaluation of di erent compositions of
niosomes to optimize aceclofenac
transdermal delivery. Asian Journal of
Pharmaceutical Sciences. 2010; 5 (3): 87–95.
11. Salih OS, Samein LH, Ali WK. Formulation
and in vitro evaluation of rosuvastatin
calcium niosomes. International Journal of
Pharmacy and Pharmaceutical Sciences. 2013;
5 (4): 525–535.
12. Shinde UA, Kanojiya SS. Serratiopeptidase
niosomal gel with potential in topical delivery.
Journal of Pharmaceutics. 2014, Article ID
382959.
13. Nakatsuji T, Kao MC, Fang JY, et al. (2009).
Antimicrobial property of lauric acid against
Propionibacterium acnes: its therapeutic
potential for inflammatory acne vulgaris. J
Invest Dermatol 129: 2480–2488.